Jian-guo Sun

Chongqing, 400038, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Weight-loss associated DNA methylation patterns: targetable biomarkers and pathway insights.

Weight-loss associated DNA methylation patterns: targetable biomarkers and pathway insights.

Journal: BMC research notes

Published: December 29, 2024

Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC.

Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC.

Journal: iScience

Published: August 20, 2024

Characterization of zinc finger protein 536, a neuroendocrine regulator, using pan-cancer analysis.

Characterization of zinc finger protein 536, a neuroendocrine regulator, using pan-cancer analysis.

Journal: European journal of medical research

Published: January 22, 2024

Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.

Population-based high-dimensional analyses identify multiple intrinsic characters for cancer vaccines against lung squamous cell carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: March 23, 2023

Mental health status and related influencing factors in patients with COVID-19.

Mental health status and related influencing factors in patients with COVID-19.

Journal: BMC psychology

Published: January 18, 2023

Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial.

Feasibility of omitting the clinical target volume under PET-CT guidance in unresectable stage III non-small-cell lung cancer: A phase II clinical trial.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: September 26, 2022

YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer.

YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer.

Journal: Canadian respiratory journal

Published: September 23, 2022

Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy.

Correlation of preclinical and clinical biomarkers with efficacy and toxicity of cancer immunotherapy.

Journal: Therapeutic advances in medical oncology

Published: August 06, 2022

Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study.

Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study.

Journal: Frontiers in oncology

Published: April 19, 2021

A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.

A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: March 31, 2021

Clinical characteristics and a decision tree model to predict death outcome in severe COVID-19 patients.

Clinical characteristics and a decision tree model to predict death outcome in severe COVID-19 patients.

Journal: BMC infectious diseases

Published: February 28, 2021

Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study.

Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study.

Journal: BMC infectious diseases

Published: January 06, 2021

Showing 1-12 of 40

Last Updated: 09/26/2026